University Hospital, Basel, Switzerland
1,106
181
227
746
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
78 terminated/withdrawn out of 1106 trials
90.5%
+4.0% vs industry average
10%
106 trials in Phase 3/4
1%
10 of 746 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1106)
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Role: lead
A Comparative Usability Study of Two Total Body Skin Imaging Systems
Role: lead
Sensory Stimulation as a Driver of Diet-induced Thermogenesis
Role: lead
Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy
Role: lead
Early Detection and IntervenTion in Heart Failure
Role: lead
ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair
Role: lead
oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias
Role: lead
Development of a Patient-Centered Assessment Tool for Pain During Cesarean Delivery
Role: lead
Micro-choice-based Intervention for Multicausal Fatigue
Role: lead
Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
Role: collaborator
Bronchoscopic Versus Airway Exchange Catheter-Guided Endotracheal Tube Exchange
Role: collaborator
Linezolid Plus Standard of Care
Role: lead
Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System
Role: lead
Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
Role: lead
Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease
Role: lead
Quality of Life Improvement During Chemotherapy
Role: lead
Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery
Role: lead
Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - The SPECTRA Study
Role: lead
Vortioxetine for Newly Diagnosed Glioblastoma
Role: collaborator
Bridging the Gap in Psychosocial Care for Cancer Survivors
Role: lead